testimonios
At LKC, we are committed to providing our customers with the comprehensive information they need to help with the treatment and diagnosis of ophthalmic disorders and enhanced patient management. Discover what other professionals and practices are saying about our devices and how they have helped them and their practice.
“Los dispositivos electrofisiológicos tradicionales suelen ser pesados, muy costosos y requieren una importante colaboración del paciente, lo que los hace menos accesibles, especialmente en regiones como América Latina. El dispositivo RETeval ERG/VEP cambia todo eso gracias a su diseño ligero y portátil y al uso de tiras de sensores adhesivas en lugar de electrodos de contacto corneales, simplifica el proceso, sobre todo para los pacientes pediátricos, incluidos los lactantes. La configuración rápida y mínimamente invasiva hace que la experiencia sea mucho menos intimidante y mucho más práctica, esto garantiza que se puedan ofrecer pruebas precisas y sin estrés a los pacientes más jóvenes.”
Dr. Ayelén Ginesta, Dra Clinic: Institute of Eyes and Ears of Resistencia in Chaco, Argentina
RETeval®
December 20, 2024
“Traditional electrophysiological devices are often heavy, expensive, and require significant patient cooperation, making them less accessible—especially in regions like Latin America. The RETeval ERG/VEP device changes all that. With its lightweight, portable design and the use of adhesive Sensor Strips instead of corneal contact electrodes, the device simplifies the process, particularly for pediatric patients, including infants. The quick, minimally invasive setup makes the testing experience far less intimidating and much more practical, ensuring we can provide accurate and stress-free testing for our youngest patients.”
Dr. Ayelén Ginesta, Dra Clinic: Institute of Eyes and Ears of Resistencia in Chaco, Argentina
RETeval®
December 20, 2024
“The first ERG examination I did was in 1987 when I was a student and It was very hard to perform examinations especially for children. When I started the modern type of ERG with skin electrodes in 2018, it was fantastic for me and I’m very enthusiastic about this method. Examining retinal ganglion cells, sometimes it’s very useful in optic nerve diseases and I would like to encourage examiners to perform ERG to make proper diganosis of optic nerve diseases.”
Prof. Dorota Pojda-Wilczek, Medical University of Silesia
RETeval®
December 13, 2024
“After using the RETevet, I feel that ERG examination can be so convenient. RETevet can be held in hand, there is no need to connect the computer when testing. The test results are stable and can automatically generate PDF files, which can clearly show the results to my customers. It’s great that the preset test protocol can be used to diagnose different diseases!”
Dr. Jie Wang, Founder and Ophthalmologists of Pet Burgh Pet Hospital Ltd., China
RETevet™
January 29, 2024
“Hi, I’m Dr. Diogo de Paula Soares, a pediatric ophthalmologist in Sinop, Mato Grosso. I’d like to briefly share my experience with RETeval. RETeval, due to its portability and the fact that it is non-invasive, as well as presenting a graphic preview of the exam on the screen, has been very well tolerated by children. It has really added a lot to my daily practice, as it clarifies a number of diagnoses, especially in premature children and those with special needs. The ability to assess retinal function using the electroretinogram and visual pathway function using the VEP (Visual Evoked Potential) has been very valuable as a diagnostic tool for my patients and for the patients of some colleagues who specifically refer them for these tests. Therefore, it has been a very interesting experience and has added a lot not only for me in my daily practice but also for my entire region in the north of Mato Grosso.”
Dr. Diogo de Paula Soare, pediatric ophthalmologist in Sinop, Mato Grosso, Brazil
RETeval®
November 5, 2023
“My experience with RETeval is very positive. The portable technology of RETeval has brought to our practice the possibility of electrophysiological diagnosis in sedation-based or not sedated exams. It is now easier to evaluate and monitor visual function, through ERG, in infants with Retinoblastoma or using the anticonvulsant Vigabatrin. But the use is not limited to Pediatric Ophthalmology. As we are in an educational service, RETeval has enabled research using the negative photopic wave in cases of glaucoma, which seems to be a good strategy for monitoring these patients, as it is related to the function of ganglion cells and also in Papilledema.”
Dr. Renata Moreto, Neuro-ophthalmologist, Hospital das Clinicas da Faculdade de Medicina da USP, Brazil
RETeval®
October 5, 2023
“I love this ERG! The RETeval has revolutionized the way we practice. It is a game-changer in functional diabetic retinopathy management and is also quite useful in glaucoma care.”
Mike Cymbor, OD, FAAO, Nittany Eye Associates, USA
RETeval®
February 3, 2023
“RETeval really has made me a better diagnostician. It has allowed me to get early information about a patient’s eye health before disease becomes clinically visible.”
Julie Rodman, OD, MS, FAAO, Nova Southeastern University
RETeval®
January 9, 2023
“As a specialist in both medical and surgical retina, I understood long time ago the important role of ERG in helping to diagnose several diseases. However, the technologies available so far on the market were not user friendly. They were complicated and time-consuming. This is perhaps one of the reasons we have all so heavily relied mainly on imaging. This changed for me after being introduced to the RETeval device from LKC Technologies…
Prof. Paulo Eduardo Stanga, The Retina Clinic London – Director & Vitreoretinal Surgeon
RETeval®
December 6, 2022
“I am a longtime user of the RETeval device. I use it all the time and was amazed at how quickly I was able to implement ERG testing with minimal disruption to the clinic.
Dr. Igor Kozak, Hospital Moorfields Eye Abu Dhabi
RETeval®
April 2, 2020
“I improved my skills under the guidance of the most outstanding European veterinary ophthalmologists…
Piotr Dąbrowski, Veterinary Doctor, Surgeon, Poland
RETevetTM
April 6, 2020
Dr. Robert J. Munger, DVM, DACVO,, Animal Ophthalmology Clinic, Ltd.
UTAS SunBurst
April 5, 2020
“I enjoy the RETevet’s ease of use and portability. The first time I started the device I was able to perform an ERG with no help at…
Martí Cairó Font, Ophthalmologist, Hospital Veterinari Canis – Girona, Spain
RETevetTM
October 24, 2019
“Our organization has implemented the RETevet device at multiple locations. The ability to visualize the animal’s eye throughout the…
Frank J. Frassetto III, ACHE, BSHM, CRT,, Chief Operating Officer, Eye Care for Animals
RETevetTM
April 6, 2020
“As someone not familiarized with ERG, I was surprised with how easy it is to perform ERG tests with the RETevet. The real time view of…
Kaisa Wickström, Veterinarian, Eläinlääkäriasema Kamu Oy – Oulu, Finland
February 6, 2020
“I added the RETevet device to my practice because of the ease of use, portability, and ability to get repeatable test results. In my…
Dr. Robert J. Munger, DVM, DACVO,, Animal Ophthalmology Clinic, Ltd.
RETevet™
February 6, 2020
We plan training sessions and visits by patients implanted with a RETINA IMPLANT Alpha AMS subretinal implant(*) in their own home…
Patient Care Manager, Retina Implant AG
RETeval®
February 6, 2020
Dr. Monique Leys, MD EBO, West Virginia University Eye Institute
RETeval®
February 6, 2020
“The handheld and portable nature of the device made it easy to bring to multiple office locations. We were able to test many patients…
Robert Feig, MD, Brooklyn Eye Center – Retina Specialist
LKC Sensor Strips
February 6, 2020
Dra. Melanie Schmitt, Universidad de Wisconsin, Facultad de Medicina y Salud Pública
RETeval®
February 6, 2020
My RETeval Experience – James Soque, Chief of Imaging
RETeval®
November 8, 2019
My RETeval Experience – Pamela Weber, MD
RETeval®
November 7, 2019
My RETeval Experience – Dara Khalatbari, MD
RETeval®
November 7, 2019
Request a demo or a quote for the RETeval Device
Warning: This product can expose you to chemicals including lead, which is known to the State of California to cause cancer and birth defects or other reproductive harm. For more information go to www.P65Warnings.ca.gov.
Substance Tables:
The table below lists substances which may be contained within LKC’s RETeval and RETevet products. Substances listed as Type 1 are within permissible levels in one or more of LKC’s products. Substances listed as Type 2 are used in the production of some components used in LKC products and may be present at trace levels, but are typically destroyed during processing.
RETeval and RETevet Devices
| Substance | CAS # | Type | Listed as causing: |
| Nickel | 7440-02-0 | 1 | Cancer |
| Acrylonitrile | 107-13-1 | 2 | |
| Ethylbenzine | 100-41-4 | 2 | |
| Crystaline Silica | 14808-60-7 | 1 | |
| Lead | 7439-92-1 | 1 | Cancer Developmental Toxicity Male Reproductive Toxicity Female Reproductive Toxicity |
| Methylene Chloride | 75-09-2 | 2 | Cancer Female Reproductive Toxicity |
| Bisphenol A | 80-05-7 | 2 | |
| N-Hexane | 110-54-3 | 2 | Male Reproductive Toxicity |